HealthDay News — Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems have been reported. The review covers Beyfortus (from Sanofi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback